monatepil
Sign in to saveMonatepil is a calcium channel blocker and α1-adrenergic receptor antagonist used as an antihypertensive.
Research
31 papers- Antihypertensive, antiatherosclerotic, and plasma lipid-lowering effects of monatepil, a novel calcium antagonist with alpha 1-adrenoceptor-blocking activity in experimental animals.American journal of hypertension · 1994
- Newer antihypertensive drugs.Current opinion in cardiology · 1995
- Effects of monatepil, a novel calcium antagonist with alpha 1-adrenergic blocking activity, on the low-density lipoprotein receptor in human skin fibroblasts.Cardiovascular drugs and therapy · 1997
- Inhibitory effect of monatepil maleate on acyl-CoA:cholesterol acyltransferase activity in the liver of cholesterol-fed Japanese monkeys.American journal of hypertension · 1997
- Effects of monatepil maleate, a new Ca2+ channel antagonist with alpha1-adrenoceptor antagonistic activity, on cholesterol absorption and catabolism in high cholesterol diet-fed rabbits.Japanese journal of pharmacology · 1998
via PubMed
~1 min read
Encyclopedic overview
2 sectionsContents
- Synthesis
- References
Monatepil is a calcium channel blocker and α1-adrenergic receptor antagonist used as an antihypertensive.
==Synthesis== The synthesis of monatepil was first disclosed in patents filed by Dainippon Pharmaceutical. upright=2|class=skin-invert-image
Excerpted from Wikipedia’s “monatepil” article, available under the CC BY-SA 4.0 licence.